{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:58:16Z","timestamp":1792623496681,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Basic Research Laboratory (BRL)","award":["2015R1A4A1042350"],"award-info":[{"award-number":["2015R1A4A1042350"]}]},{"name":"Basic Science Research","award":["2017R1A2B4008761"],"award-info":[{"award-number":["2017R1A2B4008761"]}]},{"name":"Korean government"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jpba.2017.08.048","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T22:31:46Z","timestamp":1504305106000},"page":"341-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Quantitative determination of carfilzomib in mouse plasma by liquid chromatography\u2013tandem mass spectrometry and its application to a pharmacokinetic study"],"prefix":"10.1016","volume":"146","author":[{"given":"Jee Sun","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiseon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Fen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kyung","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.08.048_bib0005","unstructured":"FDA KYPROLIS FDA Prescribing Information. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/202714s009lbl.pdf. (Accessed 6 May 2017)."},{"key":"10.1016\/j.jpba.2017.08.048_bib0010","unstructured":"EMA EMA KYPROLIS Information. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/003790\/WC500197692.pdf. (Accessed 6 May 2017)."},{"key":"10.1016\/j.jpba.2017.08.048_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/cas.13166","article-title":"Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: a phase 1 study in Japan","volume":"108","author":"Suzuki","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jpba.2017.08.048_bib0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/dmd.112.047662","article-title":"Clinical pharmacokinetics metabolism, and drug-drug interaction of carfilzomib","volume":"41","author":"Wang","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2017.08.048_bib0025","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1124\/dmd.111.039164","article-title":"Pharmacokinetics pharmacodynamics, metabolism, distribution, and excretion of carfilzomib in rats","volume":"39","author":"Yang","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2017.08.048_bib0030","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","article-title":"Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome","volume":"67","author":"Demo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2017.08.048_bib0035","doi-asserted-by":"crossref","first-page":"e0173247","DOI":"10.1371\/journal.pone.0173247","article-title":"Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: anticancer efficacy and pharmacokinetic studies in mice","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2017.08.048_bib0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpba.2016.03.015","article-title":"A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor","volume":"124","author":"Sestak","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.08.048_bib0045","series-title":"Guidance for Industry: Bioanalytical Method Validation","author":"US Department of Health and Human Services","year":"2013"},{"key":"10.1016\/j.jpba.2017.08.048_bib0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1208\/s12248-014-9573-z","article-title":"Stability: recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team","volume":"16","author":"van de Merbel","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2017.08.048_bib0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpba.2016.11.044","article-title":"A simple and sensitive liquid chromatography-tandem mass spectrometry method for trans-\u03b5-viniferin quantification in mouse plasma and its application to a pharmacokinetic study in mice","volume":"134","author":"Kim","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.08.048_bib0060","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jps.24236","article-title":"Using improved serial blood sampling method of mice to study pharmacokinetics and drug-drug interaction","volume":"104","author":"Watanabe","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.08.048_bib0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0976-500X.72350","article-title":"Blood sample collection in small laboratory animals","volume":"1","author":"Parasuraman","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.jpba.2017.08.048_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"Appl. Toxicol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517311561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517311561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T01:25:32Z","timestamp":1535419532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517311561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":14,"alternative-id":["S0731708517311561"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.08.048","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative determination of carfilzomib in mouse plasma by liquid chromatography\u2013tandem mass spectrometry and its application to a pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}